EBNA1BP2 and Hyperglycemia: Because of the high inherent variability of hyperglycemia and subsequent DR severity in individual mice, we compared the therapeutic efficacies of EBP2 and EBP3 hFabs between the left and right eyes of each DR mouse by intravitreally injecting equal doses of the blind-coded paired antibodies, as described in the Methods section.